Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Serum IFN-γ levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis

Fig. 3

Serological autoantibody profiles and changes in immune function. Anti-CCP and RF levels and the ratio of CD4+Foxp3+ Tregs to CD4+IL-17A+ Th17 cells for CD4+ T cells were measured before and after MSCT for each group. a Serum anti-CCP level; b serum RF level; c flow cytometry results for Foxp3+ Tregs and IL-17A+ Th17 cells from CD4+ T cells for each group; d ratio of CD4+CD25+Foxp3+ Tregs to CD4+IL-17A+ Th17 cells for CD4+ T cells. *P < 0.05, versus the response group before MSCT; &P < 0.05, versus the no-response and control groups according to one-way ANOVA. The error bars indicate the SEM. Anti-CCP anti-cyclic citrullinated peptide antibody, RF rheumatoid factor

Back to article page